Location History:
- Great Neck, NY (US) (2002 - 2003)
- New York, NY (US) (2000 - 2009)
Company Filing History:
7 out of 67 
2 out of 16 Years Active: 2000-2009
Title: The Innovations of Robert A. Mitchell
Introduction
Robert A. Mitchell is a prominent inventor based in New York, NY, known for his significant contributions to medical research and biotechnology. With a total of nine patents to his name, he has made substantial advancements in the field of cytokine research.
Latest Patents
Among his latest patents is the invention of Anti-MIF antibodies. This invention relates to compositions and methods for inhibiting the release and/or biological activity of migration inhibitory factor (MIF). In particular, it addresses the treatment of various conditions involving cytokine-mediated toxicity, including shock, inflammation, graft versus host disease, and autoimmune diseases. Another notable patent is the method for determining MIF content, which is a diagnostic technique for assessing MIF protein levels in a sample using direct or indirect detection methods. This MIF protein is identified as a human protein with a molecular weight of approximately 12.5 kDa.
Career Highlights
Robert A. Mitchell has worked with esteemed organizations such as the Picower Institute for Medical Research and Cytokine Pharmasciences, Inc. His work has been pivotal in advancing the understanding of cytokines and their role in various medical conditions.
Collaborations
Throughout his career, Mitchell has collaborated with notable colleagues, including Richard J. Bucala and Jurgen Bernhagen. These collaborations have further enriched his research and contributions to the field.
Conclusion
Robert A. Mitchell's innovative work in the realm of cytokine research and his numerous patents highlight his significant impact on medical science. His contributions continue to pave the way for advancements in treatment methodologies for various health conditions.